发明名称 3'-prodrugs of 2'-deoxy-beta-L-nucleosides
摘要 A 3'-substituted-beta-L-nucleoside of formula (I), and a pharmaceutically acceptable salt thereof is disclosed, wherein R1 is hydrogen, straight chained, branched or cyclic alkyl, CO-alkyl, CO-aryl, CO-alkoxyalkyl, CO-aryloxyalkyl, CO-substituted aryl, akylsulfonyl, arylsulfonyl, aralkylsulfonyl, amino acid residue, mono, di, or triphosphate, or a phosphate derivative; R2 is selected from the group consisting of straight chained, branched or cyclic alkyl, CO-alkyl, CO-aryl, CO-substituted aryl, arylsulfonyl, aralkylsulfonyl, mono, di, or triphosphate, or a phosphate derivative; X is O, S, SO2 or CH2; and BASE is a purine or pyrimidine base that may optionally be substituted. Also disclosed is the use of such a compound in the manufacture of a medicament for the treatment or prophylaxis of a hepatitis B virus infection in a host.
申请公布号 NZ535246(A) 申请公布日期 2006.06.30
申请号 NZ20010535246 申请日期 2001.06.15
申请人 IDENIX (CAYMAN) LIMITED;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS);L'UNIVERSITE MONTPELLIER II 发明人 BRYANT, MARTIN L;GOSSELIN, GILLES;IMBACH, JEAN-LOUIS
分类号 C07D239/47;A61K31/513;A61K31/7068;A61K31/7072;A61K31/7076;A61K31/708;A61K45/00;A61P31/12;A61P31/20;A61P43/00;C07H19/06;C07H19/073;C07H19/16;C07H19/173;(IPC1-7):C07H19/00 主分类号 C07D239/47
代理机构 代理人
主权项
地址